<DOC>
	<DOCNO>NCT00172198</DOCNO>
	<brief_summary>1 . A prospective , control , randomize , study evaluate clinical efficacy , include nutritional status , immune function safety Omegaven ( ω-3 fish oil ) supplement parenteral nutrition subject SICU . 2 . Study patient critical ill patient SICU NTUH enrol patient 30 subject , include 15 treatment group . 3 . During parenteral nutrition , fat emulsion give separately amino acid glucose solution . Infusion pump must used.The recommended infusion duration daily lipid emulsion 16 hour ( 0.0625 g fat/kg B.W./hour ) 8:00 12:00 pm . 4 . During study assessment safety efficacy perform accord case report form . The assessment safety variable include blood pressure、heat rate 、body temperature、liver function、renal function、coagulation、WBC、lipid profile etc . In addition，the assessment efficacy variable include lymphocytes、cytokines ( IL-1、IL-2、IL-6、IL-8、IL-11、IL-18、OX40 ligand、G-CSF、FN-γ、TGF-β1、TNF-α etc ) 、incidence infections、 length ICU hospital stay、mortality etc .</brief_summary>
	<brief_title>Omegaven ( w-3 Fish Oil ) Supplemented Parenteral Nutrition Subjects SICU .</brief_title>
	<detailed_description>1 . A prospective , control , randomize , study evaluate clinical efficacy , include nutritional status , immune function safety Omegaven ( ω-3 fish oil ) supplement parenteral nutrition subject SICU . 2 . Study patient critical ill patient SICU NTUH enrol patient 30 subject , include 15 treatment group . 3 . During parenteral nutrition , fat emulsion give separately amino acid glucose solution . Infusion pump must used.The recommended infusion duration daily lipid emulsion 16 hour ( 0.0625 g fat/kg B.W./hour ) 8:00 12:00 pm . 4 . During study assessment safety efficacy perform accord case report form . The assessment safety variable include blood pressure、heat rate 、body temperature、liver function、renal function、coagulation、WBC、lipid profile etc . In addition，the assessment efficacy variable include lymphocytes、cytokines ( IL-1、IL-2、IL-6、IL-8、IL-11、IL-18、OX40 ligand、G-CSF、FN-γ、TGF-β1、TNF-α etc ) 、incidence infections、 length ICU hospital stay、mortality etc .</detailed_description>
	<criteria>Male female patient 15 75 year age Expected ICU stay TPN support requirement &gt; 7 day Hemodynamically stable Serum bilirubin &lt; 2.5 mg/dl Serum creatinine &lt; 1.4 mg/dl INR ( international Normalized ratio PT ) &lt; 1.4 Written inform consent subject Pregnant lactating woman . ( Premenopause woman , capable bearing child undergo pregnancy test ) General contraindication infusion therapy ; acute pulmonary oedema , hyperhydration decompensated cardiac insufficiency Known hypersensitivity egg soy protein ingredient Severe blood coagulation disorder Shock necessitate acute resuscitation discretion investigator Diabetes mellitus known ketoacidosis within 7 day onset study treatment APACHE II score &gt; 25 Renal insufficiency define serum creatinine value &gt; 1.4 mg/dl Subjects severe liver dysfunction contraindicates use parenteral nutrition discretion investigator Known type IV hyperlipidemia , disturbance lipid metabolism hypertriglyceridemia ( time inclusion , blood sample ( fast ) serum triglyceride assessment take . The sample analyse start trial treatment . In case fast serum triglyceride value &gt; 4 mmol/l ( &gt; 354 mg/dl ) subject must withdraw . Unconscious uncooperative patient Participation clinical study investigational drug investigational medical device within one month prior start study</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2005</verification_date>
	<keyword>w-3 fish oil</keyword>
	<keyword>Nutrition</keyword>
	<keyword>immune</keyword>
	<keyword>intensive care</keyword>
	<keyword>patient</keyword>
</DOC>